Programme Hospitalier Recherche Clinique, Institut Pasteur, Inserm, French Public Health Agency.
Background Although lung protection with low tidal volume and limited plateau pressure ( P plat ) improves survival in acute respiratory distress syndrome patients (ARDS), the best way to set positive end-expiratory pressure (PEEP) is still debated. Methods This study aimed to compare two strategies using individual PEEP based on a maximum P plat (28–30 cmH 2 O, the Express group) or on keeping end-expiratory transpulmonary pressure positive (0–5 cmH 2 O, P Lexpi group). We estimated alveolar recruitment (Vrec), end-expiratory lung volume and alveolar distension based on elastance-related end-inspiratory transpulmonary pressure ( P L,EL ). Results Nineteen patients with moderate to severe ARDS (PaO 2 /FiO 2 < 150 mmHg) were included with a baseline PEEP of 7.0 ± 1.8 cmH 2 O and a PaO 2 /FiO 2 of 91.2 ± 31.2 mmHg. PEEP and oxygenation increased significantly from baseline with both protocols; PEEP Express group was 14.2 ± 3.6 cmH 2 O versus 16.7 ± 5.9 cmH 2 O in P Lexpi group. No patient had the same PEEP with the two protocols. Vrec was higher with the latter protocol (299 [0 to 875] vs. 222 [47 to 483] ml, p = 0.049) and correlated with improved oxygenation ( R 2 = 0.45, p = 0.002). Two and seven patients in the Express and P L,expi groups, respectively, had P L,EL > 25 cmH 2 O. Conclusions There is a great heterogeneity of P Lexpi when P plat is used to titrate PEEP but with limited risk of over-distension. A PEEP titration for a moderate positive level of P Lexpi might slightly improve alveolar recruitment and oxygenation but increases the risk of over-distension in one-third of patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.